PXL/HO/Cir-073/2018-19 Dt: 11.12.2018
Subject: Workshop on "Regulatory practices in China and Dossier filing with NMPA (formerly CFDA)" on 17thDec.2018 at Hyderabad.
Members are kindly aware, recently the regulatory requirements of China for product registration undergone many changes and guidelines of the National Medical Products Administration, China (formerly CFDA), which will likely have an impact on the dossier filing and timelines of the product approvals.
With a view to create awareness on the recent developments on the product registration guidelines and dossier filing with The National Medical Products Administration(NMPA -formerly CFDA) Pharmexcil is organizing a full day workshop in association with M/s. China Chino pharma Ltd, one of the major trading company , for the benefit of our member companies.
The details of the program are as follow:
Date : 17th December 2018
Timings: 8.30 am to 5.30pm
Venue: Park Hyatt, Hyderabad
The workshop will have sessions on the NMPA recent regulatory requirements and technical guidelines for Dossier filling with NMPA and guidance on facing audits, challenges and opportunities under the update guidelines. The detailed program is attached.
Member companies interested to participate in the workshop are requested to register their participation by sending email to firstname.lastname@example.org. Kindly note that the seats are limited.